Hennion & Walsh Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,831
| Closed | -$1.4M | – | 896 |
|
|
2023
Q4 | $1.4M | Buy |
23,831
+1,295
| +6% | +$76.1K | 0.08% | 321 |
|
|
2023
Q3 | $982K | Buy |
22,536
+1,284
| +6% | +$55.9K | 0.06% | 362 |
|
|
2023
Q2 | $768K | Sell |
21,252
-47
| -0.2% | -$1.7K | 0.05% | 423 |
|
|
2023
Q1 | $792K | Buy |
21,299
+1,536
| +8% | +$57.1K | 0.05% | 406 |
|
|
2022
Q4 | $895K | Buy |
19,763
+10,436
| +112% | +$473K | 0.06% | 366 |
|
|
2022
Q3 | $651K | Buy |
9,327
+2,326
| +33% | +$162K | 0.04% | 427 |
|
|
2022
Q2 | $470K | Buy |
+7,001
| New | +$470K | 0.03% | 497 |
|
|
2021
Q4 | – | Sell |
-8,478
| Closed | -$1.5M | – | 792 |
|
|
2021
Q3 | $1.5M | Sell |
8,478
-2,782
| -25% | -$492K | 0.08% | 274 |
|
|
2021
Q2 | $1.82M | Sell |
11,260
-14,134
| -56% | -$2.28M | 0.1% | 256 |
|
|
2021
Q1 | $4.35M | Buy |
+25,394
| New | +$4.35M | 0.26% | 100 |
|